Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03289156 · ClinicalTrials.gov registry record · NA

Strategies for Responding to Stress

A NA study of Stress, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT03289156: Completed NA study of Stress, sponsored by University of Texas at Austin.

NCT03289156 is a NA study of Stress that has completed, run by University of Texas at Austin. The registered enrollment target is 160 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03289156, a NA study of Stress, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine whether changes in psychological and physiological responses differ based on different strategies for responding to stress.

Primary Outcome

Self-report ratings of appraisal of a lab based stressor as threatening or challenging.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Arousal Reappraisal

Study Locations (1)

Texas

  • University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2017-09-18
Est. Completion 2019-05-30
Phase NA
University of Texas at Austin

257 total trials

What the finished NCT03289156 record still lists

NCT03289156 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT03289156 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03289156 about?

NCT03289156 is a clinical study titled "Strategies for Responding to Stress". The purpose of this study is to examine whether changes in psychological and physiological responses differ based on different strategies for responding to stress.

What is the current status of trial NCT03289156?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2017-09-18. Estimated completion is 2019-05-30.

What conditions does trial NCT03289156 study?

This clinical trial studies the following conditions: Stress.

What interventions are being tested in trial NCT03289156?

The interventions under investigation include: Exercise (BEHAVIORAL), Arousal Reappraisal (BEHAVIORAL).

Who is sponsoring clinical trial NCT03289156?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03289156 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03289156's enrollment target sits among peer trials

160 40th of 152 higher than 111 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03289156, the US trial registry maintained by the National Library of Medicine. NCT03289156 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.